rituximab
roche,biogen
[]
caution about stopping rtx in aav 25% relapse at 4.5yrs when rtx stopped around 3 yrs relapse rates higher in pts with prior relapse, baseline +pr3, persistence or recurrence of anca monitor closely if rtx stopped #acrambassador #acr22 #clinicalpearl 
mom,rheumatologist,VP @PaRheum, local leader @AWIRGROUP,#ACRambassador, #ACR22  Tweets#medical advice